Gene Therapy INDs In China: Five Things To Consider

 
• By Brian Yang
  
China CDE's senior reviewer Huang Hongyun on cell therapy development during China Rare Disease Summit, 9/15/18 • Source: The Pink Sheet

More from China

More from Asia